My Medical CD Rated 'Speculative/3' By Investrend Research Analyst Oren Meytes, Citing 'Hot Market Niche'.

NEW YORK -- (Investrend Research Syndicate) My Medical CD (OTC: MYMC) has been rated "Speculative / 3" by Investrend Research analyst Oren Meytes, in an initiating Benchmark research report, saying the company "operates in a hot field - electronic medical records."

The analyst stated:

This field has been getting a lot of attention by legislators, health officials, insurance companies, HMO's and of course the medical software companies who are trying to rise up to the challenge. As of yet there is no nation-wide system for computerized patient records. My medical CD is a small start-up company, which is trying to carve a niche for itself in this burgeoning industry.

Health care is rarely delivered at a single geographic site. Patients go to one office to see their gynecologists, to another for dental work. Increasingly many routine lab tests and radiological procedures are now performed and interpreted by outside clinics rather than by labs located within the hospital walls.

The electronic medical record offers the possibility of a centralized database that can hold the patient's entire medical history, from childhood pediatric visits to geriatric records.

My Medical CD Ltd. produces and markets an interactive mini CD that contains a personal medical history encoded on the CD. The size enables it to be carried in the wallet, pocket or purse. Benefits of the CD include: (i) It can be read in seconds by emergency personnel, (ii) It eliminates guesswork in treatment, and (iii) It reduces the possibility of long-term complications from emergency treatment.

Government and legislators are very supportive of the computerization of medical records and of the idea that people should have greater control over their medical records and carry pertinent information on their person.

My Medical CD's approach is to sell to the patient - either directly or via an organization in which he is a member.

The full report, including important disclosures and disclaimers, is at http://www.investrendresearch.com and at the company's InvestorPower page at http://www.investrend.com/company/list.asp?sPathParam=yes and investors are advised to read those disclosures carefully before trading in the equities of any enrolled company.

The analyst's credentials are at http://www.investrend.com/articles/secondlevel.asp?level=238

My Medical CD is enrolled in Investrend Research's pioneering professional research program, which facilitates independent analysts to provide financial coverage for shareholders in companies that otherwise, would have little or no analyst following. Enrollment fees for Benchmark basic coverage are $21,800 and the fees were paid by the company. Analysts are paid in advance of initial reports by Investrend Research to eliminate pecuniary interest, and neither the analyst nor principals of Investrend Research may own or trade in the stocks of companies under coverage.

Anyone interested in receiving alerts regarding My Medical CD research should email [e-mail] with "MYCD" in the subject line.